Needham Reiterates Buy Rating on Hologic (HOLX)

December 19, 2024 6:05 AM UTC Send to a Friend
Needham analyst Mike Matson reiterated a Buy rating and $90.00 price target on Hologic (NASDAQ: HOLX).The analyst commented: "Management expects ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login